Result of Annual General Meeting To download click here Wednesday 23 November 2022 16:47 Categories: News Regulatory News Year - 2022
Scancell in-licenses Vaccitech technology to advance Modi-2 towards the clinic To download click here Monday 7 November 2022 09:54 Categories: Modi-2 Moditope News Regulatory News Year - 2022
First patient dosed in the expansion phase of the monotherapy arms of ModiFY To download click here Monday 31 October 2022 09:01 Categories: Modi-1 Moditope News Regulatory News Year - 2022
Preliminary Results for the year ended 30 April 2022 To download click here Friday 28 October 2022 07:41 Categories: News Regulatory News Year - 2022
Scancell signs Commercial License Agreement with Genmab To download click here Tuesday 25 October 2022 11:48 Categories: GlyMab News Regulatory News Year - 2022
Scancell Change of Registered Office To download click here Tuesday 6 September 2022 13:04 Categories: News Regulatory News Year - 2022
First patient dosed in Cohort 2 of the ModiFY Phase 1 clinical trial To download click here Tuesday 16 August 2022 14:16 Categories: Modi-1 News Regulatory News Year - 2022
Scancell to produce and clinically validate T cell redirecting bispecific antibodies To download click here Thursday 23 June 2022 10:38 Categories: GlyMab News Regulatory News Year - 2022
Phase 2 SCOPE trial of SCIB1 vaccine in metastatic melanoma patients expanded To download click here Wednesday 15 June 2022 11:03 Categories: News Regulatory News SCIB1 Year - 2022
First patient dosed in Modi-1 Phase 1 clinical trial To download click here Monday 13 June 2022 14:16 Categories: Modi-1 Moditope News Regulatory News Year - 2022